Dakota Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,487
Closed -$273K 571
2022
Q2
$273K Buy
+4,487
New +$273K 0.03% 385